Pharmafile Logo

Kathy O’Connell joins Research Partnership as Senior Vice President, Business Development

April 29, 2024 | Insights, US, healthcare, market research 

- PMLiVE

Kathy has been working in the pharmaceutical market research industry for over 25 years. She has a diverse business background, with in-depth experience in progressively responsible sales, business development and client management. Throughout her career, Kathy has worked extensively at guiding her clients to identify the optimal research approach to address the business issue at hand. In Kathy’s most recent position as Senior Vice President, Business Development at ThinkGen, she was responsible for implementing the business development and marketing strategy and overseeing all client outreach.

In 2023, Kathy was honored with the Healthcare Businesswomen’s Association (HBA) Luminary Award which recognizes professionals who have made a significant impact on the healthcare industry and have a proven track record of helping advance careers of other women. Kathy also volunteered as a HBA mentor as part of the HBA Mentoring Program.

In this pivotal role at Research Partnership, Kathy will be working with our Commercial Team to identify new business opportunities, nurture existing partnerships and enhance our US based presence in the market.  

US President, Sue Wild commented “I am delighted to welcome Kathy to the team, she has extensive experience and will be instrumental in nurturing our client relationships in the US market. I look forward to collaborating with Kathy to strengthen our offerings in delivering the best possible insights for our valued clients”.

Find out more. 

This content was provided by Inizio

Company Details

 Latest Content from  Inizio 

Delivering multi-stakeholder patient journey insights in oncology with creative outputs and data visualisation

Two clients were co-developing a product and needed to understand the patient journey in two areas of oncology, in order to identify the leverage points where they could provide an...

Webinar: Understanding Patient Willingness to Pay

What steps should pharma and medical device companies take to ensure they get their pricing strategy right in self-pay markets?

Research Partnership welcomes 22 new Graduates

As part of our continued growth, we are delighted to announce a new intake of 17 Research Analysts and 5 Fieldwork Project Coordinators into our annual market research graduate programme.http://www.researchpartnership.com/news/2016/09/new-graduates-2016/

Case study: Tracking a product launch in a dynamic and competitive market

With the imminent expected approval and launch of a new product, our client needed to conduct global tracking research to understand knowledge, perceptions, awareness and recall around their product and the quality...

Understanding the Chronic Disease Patient Journey in Emerging Markets

The benefits of understanding the patient journey are well documented in mature markets. But in emerging markets the patient journey is less understood. We recently presented a webinar hosted by...

Latest wave of Therapy Watch IBD to run this month

The IBD syndicated market tracker is part of our large auto-immune portfolio

Research Partnership launches new patient report – Living with Lupus (SLE)

Living with Lupus (SLE) is a quantitative study conducted online amongst patients in the US and European markets. The report will consist of 30-minute face to face interviews with a...

Webinar: Ensuring an Actionable Segmentation

A segmentation study comes with high visibility and high stakes across your marketing and sales organisations. Ensuring that a segmentation is actionable is a consistent issue, particularly when stakeholders with multiple...

Interactive infographic: LATAM

An overview of the six most-commonly researched, largest pharma markets in Latin America

Immuno-oncology: The market opportunity for PD-1/PD-L1s

Immuno-oncology is the new frontier in cancer treatment. Using the body’s own immune system to treat cancer, new therapies are producing impressive survival benefits, with reduced side effects. Of these therapies,...